Abstract
In order to investigate the possibility of using [1-11C] labelled 3,4-dihydroxyphenylalanine (DOPA) and tyrosine as radiopharmaceuticals for the detection of eye melanoma, the biodistributions of the same 1- and 3-14C-labelled compounds were investigated in Syrian golden hamsters with Greene melanoma. The results of these investigations were compared with positron emission tomography (PET) images of 11C labelled DOPA and tyrosine. The synthesis of these 11C labelled compounds procures of DL mixture, from which D and L forms can be separated. One h after intravenous injection, both 14C labelled DL-, L-and D-DOPA showed a high uptake in tumour tissue, that of DL- and D-DOPA being the highest. These high uptakes, together with relatively low uptake in bone, skin and eye resulted in high tumour/non tumour ratio (for DL-DOPA 5.9, 4.5 and 6.6 respectively). Extraction of the tumour tissue with trichloroacetic acid showed that L-DOPA was mainly incorporated into melanin, whereas D-DOPA was not. Also, the uptake 1 h after intravenous injection of 1-14C-L- and DL-tyrosine into the tumour were high, but L- and DL- were less different; tumour/non tumour ratios were favorable. PET images of the tumour obtained 40–80 min after injection of the [1-11C] labelled DOPA and tyrosine confirmed that melanoma detection was promising and that D-DOPA produced a better melanoma image than L-DOPA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blois MS, Kallman RF (1964) The incorporation of 14C from 3,4-dihydroxyphenylalanine-2′-14C into the melanin of mouse melanomas. Cancer Res 24:863–868
Bolster JM, Vaalburg W, van Veen W, van Dijk Th, van der Molen HD, Wijnberg H, Woldring MG (1983) Synthesis of no-carrieradded L- and D-[1-11C]-DOPA. Int J Appl Rad Isot 34:1650–1652
Bolster JM, Vaalburg W, van Dijk T, Zijlstra JB, Paans AMJ, Wijnberg H, Woldring MG (1985a) Synthesis of carbon-11 labelled ornithine and lysine. Preliminary accumulation studies in rats with Walker 256 carcinosarcoma. Int J Appl Rad Isot 36:263–267
Bolster JM, ten Hoeve W, Vaalburg W, van Dijk Th, Zijlstra JB, Paans AMJ, Wijnberg H, Woldring MG (1985b) The preparation of Carbon-11 labelled proline for positron emission tomography. Preliminary distribution studies in rats with Walker 256 carcinosarcoma. Int J Appl Rad Isot 36:339–343
Bolster JM, Vaalburg W, Paans AMJ, van Dijk T, Elsinga PH, Zijlstra JB, Piers DA, Mulder NH, Woldring MG, Wijnberg H (1985c) Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET). Eur J Nucl Med 12:321–324
Borri Voltattorni C, Minelli A, Dominici P (1983) Interaction of aromatic amino acids in D and L forms with DOPA decarboxylase from pig kidney. Biochemistry 22:2249–2254
Boyd CM, Beierwaltes WH, Lieberman LM, Bergstrom TJ (1971) Diagnostic efficacy of a radioiodinated chloroquine analog in patients with malignant melanoma. J Nucl Med 12:601–605
Coderre JA, Packer S, Fairchild RG, Greenberg D, Laster B, Micca P, Fand I (1986) Iodothiouracil as a melanoma localizing agent. J Nucl Med 27:1157–1164
Diksic M, Farrokhzad S (1985) New synthesis of fluorine-18-labeled 6-fluoro-L-DOPA by cleaving the carbon-silicon bond with fluorine. J Nucl Med 26:1314–1318
Fimian WJ, Dowd GA (1959) Quantiative determination of C14-tyrosine absorption in melanated and non-melanated mouse tissues. Proc Soc Exptl Biol Med 102:95–97
Gelbard AS, Benua RS, Laughlin JS, Rosen G, Reiman RE, McDonald JM (1975) Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate J Nucl Med 20:782–784
Greene HSN (1958) A spontaneous melanoma in the hamster with a propensity for amelanotic alteration and sarcomatous transformation during transplantation. Cancer Res 18:422–425
Hempel K, Deimel M (1963) Untersuchungen zur gezielten Strahlentherapie des Melanoms und des chromaffinen Systems durch selektive H-3-Inkorporation nach Gabe von H-3-markiertem DOPA. Strahlentherapie 121:22–45
Kloster G, Bockslaff H (1982) L-3-123I-α-methyltyrosine for melanoma detection: a comparative evaluation. Int J Nucl Med Biol 9:259–269
Knapp WH, Helus F, Layer K, Panzer M, Höver KH, Ostertag H (1986) Nitrogen-13 glutamate uptake and perfusion in Walker 256 carcinosarcoma before and after single-dose irradiation. J Nucl Med 27:1604–1610
Kubota K, Yamada K, Fukada H, Endo S, Ito M, Abe Y, Yamaguchi T, Fujiwara T, Sato T, Kengo I, Yoshioka S, Hatazawa J, Matsuzawa T, Iwata R, Ido T (1984) Tumor detection with carbon-11-labelled amino acids. Eur J Nucl Med 9:136–140
Mason HS (1955) comparative biochemistry of the phenolase complex. Advan Enzymol 16:105–184
Mason HS (1956) Structures and functions of the phenolase complex. Nature 177:79–81
Meier DA, Beierwaltes WH, Counsell RE (1967) Radioactivity from labeled precursors of melanin in mice and hamsters with melanomas. Cancer Res 27:1354–1359
Meyer GJ, Schober O, Hundeshagen H (1985) Uptake of 11C-L-and-D-methionine in brain tumors. Eur J Nucl Med 10:373–376
Paans AMJ, de Graaf EJ, Welleweerd J, Vaalburg W, Woldring MG (1982) Performance parameters of a longitudinal tomographic positron imaging system. Nucl Instr Methods 192:491–500
Packer S, Lambrecht RM, Christman DR, Azzizullah NA, Wolf AP, Atkins HL (1977) Metal isotopes used as radioactive indicators of ocular melanoma. Am J Ophthalmol 83:80–94
Reiffers S, Beerling-van der Molen HD, Vaalburg W, ten Hoeve W, Paans AMJ, Korf J, Woldring MG, Wijnberg H (1977) Rapid synthesis and purification of carbon-11 labelled DOPA: a potential agent for brain studies. Int J Appl Rad Isot 28:955–958
Schober D, Duden C, Meyer GJ, Müller JA, Hundeshagen H (1987) Non-selective transport of [11C-methyl]-L- and D-methionine into a malignant glioma. Eur J Nucl Med 13:103–105
Tamemasa O, Goto R, Takeda A, Maruo K (1982) High uptake of 14C labeled D-amino acids by various tumors. Gann 73:147–152
Turner HJ, Mazière M, Comar D (1985) Localization of 11C-radiopharmaceuticals in the Greene melanoma of hamsters. Eur J Nucl Med 10:392–397
Vaalburg W, Bolster JM, Paans AMJ, Zijlstra JB, van Dijk Th, Smid M, Woldring MG (1984) C-11 labeled tyrosine for investigation of tumor metabolism by positron emission tomography. J Label Complet Radioisot 21:1177
Van Langevelde A, Beerling-van der Molen HD, Journée-de Korver JG, Paans AMJ, Vaalburg W (1981) C-11 labeled melanin precursors as radiopharmaceuticals for the detection of eye melanoma. J Nucl Med 22:P76
Van Langevelde A, Bakker CNM, Broxterman HJ, Journée-de Korver JA, Kaspersen FM, Oosterhuis JA, Pauwels EKJ (1983) Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives. Eur J Nucl Med 8:45–51
Van Langevelde A, Bakker CNM, Boer H, Ilmer TAM, Journée-de Korver JA, Kaspersen FM, Noach EL, Oosterhuis JA, Pauwels EKJ (1986) Potential radiopharmaceuticals for the detection of ocular melanoma. Part II. Iodoquinoline derivatives and 67Ga-citrate. Eur J Nucl Med 12:96–104
Wick MM, Kramer RA, Gorman M (1978) Enhancement of L-DOPA incorporation into melanoma by DOPA decarboxylase inhibition. J Invest Dermatol 70:358–360
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Langevelde, A., van der Molen, H.D., Journée-de Korver, J.G. et al. Potential radiopharmaceuticals for the detection of ocular melanoma. Eur J Nucl Med 14, 382–387 (1988). https://doi.org/10.1007/BF00254389
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00254389